STXSStereotaxis, Inc.

AMEX · US · Healthcare · Medical Instruments & Supplies · stereotaxis.com

1.420USD+2.90%Mkt Cap: 142.29M $P/E: —3d ago

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic n…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap142.29M $

Enterprise Value142.20M $

Revenue (TTM)30.07M $

Gross Profit17.07M $

Net Income (TTM)-21.64M $

Revenue/Share0.3110 USD

Last Price1.420 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees131

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-9.16

PEG1.31

EV/EBITDA-7.88

EV/Revenue4.73

P/S4.73

P/B11.36

EPS (TTM)-0.24

EPS (Forward)-0.15

52W Range

1.2408% of range3.590

52W High3.590 USD

52W Low1.240 USD

Profitability

Gross Margin52.73%

Oper. Margin-59.56%

EBITDA Margin-60.06%

Profit Margin-66.85%

ROE-115.61%

ROA-41.42%

Growth

Revenue Growth-12.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-13.69M $

CapEx (TTM)93.00K $

FCF Margin-29.37%

FCF Yield-6.21%

Net Debt-5.32M $

Net Debt/EBITDA0.29

Balance Sheet

Debt/Equity0.29

Current Ratio1.42

Quick Ratio0.91

Book Value/Sh0.1250 USD

Cash/Share0.1050 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1096:1000

Split DateNov 4, 2013

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.125 USD

Upside (mean)+190.5%

Target Range3.500 USD – 5.000 USD

$3.500+190.5% to mean$5.000

# Analysts4

Ownership

Shares Out.100.20M

Float65.54M

Insiders21.15%

Institutions43.79%

Short Interest

Short Ratio3.6d

Short % Float5.32%

Short % Out.4.50%

Shares Short4.48M

Short (prev mo.)4.26M

Technical

SMA 501.564 (-9.2%)

SMA 2002.008 (-29.3%)

Beta1.40

S&P 52W Chg19.18%

Avg Vol (30d)1.08M

Avg Vol (10d)706.12K

Technical Indicators

RSI (14)46.8

MACD-0.0473

MACD Signal-0.0653

MACD Hist.+0.0180

BB Upper1.481 USD

BB Middle1.369 USD

BB Lower1.256 USD

BB Width16.49%

ATR (14)0.0945 USD

Vol Ratio (20d)0.43x